Alex Barlow

During his career Mr. Barlow has won verdicts on behalf of his clients in the areas of toxic tort, catastrophic injury, and commercial litigation, among them:

• $10.4 million, Castillo v. Garlock Castillo, et al. v. Garlock Inc., No. 97-4051 (TX Cty. Ct., El Paso Cty., Nov. 1, 1999);
• $8.2 million, Raper v. Pittsburg Corning; and
• $4.8 million, Wigley v. Georgia Pacific.

Mr. Barlow serves on the Executive Committee, the Science & Experts Committee, the Trial Committee and the Settlement Committee of MDL 3081. His role involves developing experts, deposing key adverse witnesses and defense experts, and shaping the litigation strategy for the Plaintiffs’ steering Committee. He is also slated to be a lead lawyer in the bellwether trials.

In 2021, Mr. Barlow was selected as lead trial counsel on behalf of Massachusetts communities devastated by the opioid epidemic.  He directed the legal strategy for 26 cities and towns in their public nuisance claims, managing cases in both Massachusetts Superior Court and the Federal Opiate MDL (MDL 2804) before Judge Polster until the claims were successfully resolved.

Mr. Barlow was the lead lawyer in achieving settlements totaling over $80 million in the transvaginal mesh litigation.  He was also a member of the corporate discovery team spearheading the case against Ethicon in this litigation.

In past pharmaceutical litigation, Mr. Barlow represented and achieved a confidential settlement on behalf of over 700 male children who developed gynecomastia from taking Janssen Pharmaceuticals’ antipsychotic drug, Risperdal.

Mr. Barlow has represented the Attorneys General of eight states against GlaxoSmithKline over the mis-marketing of its blockbuster diabetes drug Avandia, achieving settlements that collectively exceeded $220 million.  He also represented two Oklahoma quasi-governmental health and retirement entities in litigation against Merc over its drug, Vioxx.  Mr. Barlow has also served as counsel for thousands of men and women who suffered cardiovascular injuries from ingesting Avandia.

In Mr. Barlow’s most interesting and challenging pro bono case, he facilitated the return parental visitation rights to the mother of two children after her ex-husband, residing with the children in Malaysia, cut off her access for five years in contravention of U.S. court orders.

Mr. Barlow has an AV—Preeminent peer review rating from Martindale-Hubbell.  Currently, he is a President’s Club member of the American Association for Justice, and a member of Trial Lawyers for Public Justice.  He is a past member of the Board of the Texas Trial Lawyers Association.

In law school, Mr. Barlow was the recipient of the George E. Seay Endowed Presidential Scholarship and was a member of the Order of the Coif, a national honorary society for law school students.

INVITED LECTURES:

• Emerging Mass Torts, TTLA Year-End CLE
• How to Win on Cross-examination, TTLA Las Vegas Seminar
• Circumstantial Evidence of Scientific Causation, TTLA Mid Year CLE
• Deceptive Trade Practices in Commercial Litigation, TTLA Commercial Litigation Seminar
• Nursing Home Abuse & Neglect Case Evaluation, University of Mississippi Tort Law Seminar
• The Future of Mass Torts, University of Mississippi Tort Law Seminar
• Trying the Low Exposure Asbestos Case, Plaintiff’s Asbestos Litigation Seminar